I recognize the serious impact prescription drug prices have on all Americans. We all have constituents facing the same problem: drug prices are too high. We all want to come together to find a way to lower drug prices. Where we separate…
Greg Walden
The Public Record
Greg Walden is a former U.S. Representative from Oregon, serving in the House from 1999 to 2021. A member of the Republican Party, he represented Oregon's 2nd congressional district. During his tenure, Walden was known for his work on issues related to healthcare, telecommunications, and energy policy. He played a significant role in the passage of the 21st Century Cures Act, which aimed to accelerate medical product development and bring new innovations to patients more quickly.
Again, I appreciate the gentleman's hard work on this issue. I know we share a common goal of getting drug prices down and meeting unmet needs of cures. But, tragically, the Democrat bill, H.R. 3, is a very partisan bill. We are told by…
On that I demand the yeas and nays. The yeas and nays were ordered. The SPEAKER pro tempore (Ms. Craig). This will be a 5-minute vote. The vote was taken by electronic device, and there were--yeas 230, nays 192, not voting 8, as follows…
We certainly support clinical trials at the National Institutes of Health. In fact, the Republicans have led on this issue. In fact, Republicans have led for decades in increasing the funding for NIH, going clear back to about 1995 when…
I demand a recorded vote. The Acting CHAIR. Pursuant to clause 6 of rule XVIII, further proceedings on the amendment offered by the gentleman from Oregon will be postponed. Amendment No. 2 Offered by Mr. Tonko The Acting CHAIR. It is now…
I thank the gentleman for offering his amendment today, and I really do. We work a lot of with Mr. Gottheimer on a number of issues before the Congress, and I appreciate his commitment to this cause. Republicans fully support the goal of…
I appreciate the gentlewoman's comments. Ours is the only bipartisan bill. Thirty-six different provisions passed out of either the Ways and Means or Energy and Commerce Committee with unanimous, bipartisan support, all these provisions…
May I inquire how much time I have remaining? The Acting CHAIR (Mr. Cartwright). The gentleman from Oregon has 30 seconds remaining.
I know the Democrats yesterday said: We don't care. It is worth it. We don't need all those cures. That is, in effect, what they said. And then they said: Oh, those are just somebody's talking points. No. This is the Congressional Budget…
That is true on the bipartisan, but every provision in the bill has Democratic support as individual bills in other sectors. We brought only bipartisan bills into this alternative. Mr. Chair, I yield back the balance of my time.
It is important to know that in our substitute we cut the costs of cancer treatment for seniors in half, as well. There is bipartisan agreement on this. In fact, everything in our substitute is bipartisan. It is also important to note that…
Let me say in response, the CBO also said 38 new cures as a result of H.R. 3 will never come about. The Council of Economic Advisers says 100 new cures will never come about. H.R. 3, the underlying bill the majority wants to put into law…
May I inquire as to how much time each side has remaining. The Acting CHAIR. The gentleman from Oregon has 18 minutes remaining. The gentlewoman from Michigan has 17\1/2\ minutes remaining.
I appreciate the distinguished majority leader's comments about President Trump. I have been around Congress for 21 years, and I have never seen a President of either party lean more forward in trying to get down the cost of prescription…
I am opposed to the amendment and seek time in opposition. The Acting CHAIR. The gentleman from Oregon is recognized for 5 minutes.
I demand a recorded vote. The Acting CHAIR. Pursuant to clause 6 of rule XVIII, further proceedings on the amendment offered by the gentlewoman from Virginia will be postponed. Amendment No. 11 Offered by Mr. Cunningham The Acting CHAIR…
I have an amendment at the desk. The Acting CHAIR. The Clerk will designate the amendment. The text of the amendment is as follows: Strike all after the enactment clause and insert the following: SECTION 1. SHORT TITLE. This Act may be…
I thank the gentleman from Ohio for his remarks. I am hopeful that, after this political exercise of H.R. 3 is done, we can work on a bipartisan basis on needed part D modernization like we were doing before the Speaker, unfortunately…
I appreciate the gentleman for bringing up this important issue. Madam Chair, I reserve the balance of my time.
My friends on the other side, the Democrats, ignore these facts. Some have even said--can you imagine this--that it is ``worth it'' to forego cures. Seriously? That it is worth it to never have a cure for Alzheimer's? Is it worth it to…
May I inquire how much time is remaining. The Acting CHAIR. The gentleman from Oregon has 1 minute remaining. The gentleman from New Jersey has 3\1/2\ minutes remaining.
I want to say that we cannot lose sight of how anti-innovation H.R. 3 is. We cannot lose sight of how many cures will never come around as a result. These aren't my conclusions. They are, but they are also the conclusions of the…
I include a list of the drugs not covered by the VA into the Record. They only cover 24 of the top 50 nonvaccine Medicare part B drugs on the VA formulary. I also include a list of available medications in H.R. 3 reference countries. Top…
The Congressional Budget Office, they also looked at H.R. 3, Speaker Pelosi's bill, and they said it would kill off more than 38 new medical innovations--38. The Council of Economic Advisers, they looked at it and said they thought it…





